| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.016 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.012 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |